Epigenomics AG / Key word(s): Conference 10.12.2014 / 09:30 Epigenomics to present at the Oppenheimer 25th Annual Healthcare Conference
Berlin (Germany) and Germantown, MD (U.S.A.), December 10, 2014 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics company, today announced that CEO/CFO Dr. Thomas Taapken will be presenting at the Oppenheimer 25th Annual Healthcare Conference on Wednesday, December 10, 2014, at 9.45 a.m. EST in room ACT IV of The Crowne Plaza Hotel in New York City, USA. The Oppenheimer 25th Annual Healthcare Conference will take place on December 10-11, 2014 and is one of the most important international investor conferences introducing a broad spectrum of public and private healthcare companies spanning all major sectors of the healthcare industry. The presentation will be available on Epigenomics’ website: https://www.epigenomics.com/en/news-investors.html. – Ends – Contact Epigenomics AG Antje Zeise, Manager IR | PR For US press inquiries: Epigenomics, Inc. About Epigenomics Epigenomics legal disclaimer The information contained in this communication does not constitute nor imply an offer to sell or transfer any product, and no product based on this technology is currently available for sale by Epigenomics in the United States or Canada. The analytical and clinical performance characteristics of any Epigenomics product based on this technology which may be sold at some future time in the U.S. have not been established.
10.12.2014 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English | |
Company: | Epigenomics AG | |
Geneststraße 5 | ||
10829 Berlin | ||
Germany | ||
Phone: | +49 30 24345-0 | |
Fax: | +49 30 24345-555 | |
E-mail: | ir@epigenomics.com | |
Internet: | www.epigenomics.com | |
ISIN: | DE000A11QW50 | |
WKN: | A11QW5 | |
Listed: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart | |
End of News | DGAP News-Service |
|
304099 10.12.2014 |